Bruno Moulin

Active 1992–2025

91
Papers
33,758
Citations
60
h-index
89
i10-index

Citations

Citations per year for Bruno Moulin1993: 3 citations1994: 1 citations1995: 1 citations1996: 3 citations1998: 1 citations1999: 1 citations2001: 1 citations2002: 1 citations2003: 5 citations2004: 7 citations2005: 7 citations2006: 12 citations2007: 11 citations2008: 5 citations2009: 28 citations2010: 53 citations2011: 119 citations2012: 188 citations2013: 427 citations2014: 485 citations2015: 469 citations2016: 493 citations2017: 361 citations2018: 301 citations2019: 1,016 citations2020: 1,088 citations2021: 1,050 citations2022: 631 citations2023: 345 citations2024: 539 citations2025: 183 citations2026: 3 citations1997: no citations, so this year is not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,281 citing papers, 14.9% of this breakdownUnited Kingdom: 1,266 citing papers, 8.3% of this breakdownItaly: 1,017 citing papers, 6.6% of this breakdownGermany: 911 citing papers, 6% of this breakdownFrance: 899 citing papers, 5.9% of this breakdownNetherlands: 782 citing papers, 5.1% of this breakdownSpain: 636 citing papers, 4.2% of this breakdownChina: 537 citing papers, 3.5% of this breakdownCanada: 472 citing papers, 3.1% of this breakdownSweden: 470 citing papers, 3.1% of this breakdownAustralia: 449 citing papers, 2.9% of this breakdownSwitzerland: 381 citing papers, 2.5% of this breakdown
0%14.9%Other 33.9%

Fields

  • Medicine79.5%
  • Immunology and Microbiology8.3%
  • Biochemistry, Genetics and Molecular Biology5.4%
  • Health Professions1.3%
  • Nursing1.1%
  • Agricultural and Biological Sciences0.8%
  • Other3.6%

Topics

  • Heart Failure Treatment and Management3.4%
  • Lipoproteins and Cardiovascular Health3.4%
  • Complement system in diseases2.8%
  • Renal Transplantation Outcomes and Treatments2.6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.5%
  • Cardiovascular Function and Risk Factors2.5%
  • Other82.8%

Coauthors

All papers

Open in search
  1. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen J. Bax, H. Baumgartner, Claudio Ceconi, V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, A. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, Bogdan A. Popescu, Z. Reiner, U Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, A. Vahanian, Stephan Windecker, Document Reviewers:, Christian Funck‐Brentano, P. A. Sirnes, Victor Aboyans, Eduardo Alegría Ezquerra, Colin Baigent, Carlos Brotons, G. Burell, Antonio Ceriello, Johan De Sutter, J. Deckers, Stefano Del Prato, H.‐C. Diener, Donna Fitzsimons, Zlatko Fras, Rainer Hambrecht, Piotr Jankowski, U Keil, Mike Kirby, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios Manolis, John J.V. McMurray, A. Pajak, Alexander Parkhomenko, Loukianos Rallidis, Fausto Rigo, Evangelista Rocha, Luís M. Ruilope, Enno T. van der Velde, Diego Vanuzzo, Margus Viigimaa, Massimo Volpe, Olov Wiklund, C. Wolpert - European Heart Journal 2012 cited by 8,519

  2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Theresa A. McDonagh, Udo Sechtem, Luis Almenar Bonet, Panayiotis Avraamides, Hisham A. Ben Lamin, Michele Brignole, António Coca, Peter J. Cowburn, Henry Dargie, Perry Elliott, Frank A. Flachskampf, Giuseppe Guida, S Hardman, Bernard Iung, Béla Merkely, Christian Mueller, J. Nanas, Olav Wendelboe Nielsen, Stein Ørn, John Parissis, Piotr Ponikowski - European Heart Journal 2012 cited by 6,906

  3. Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lothar Bernd Zimmerhackl, Tim Goodship, Chantal Loirat - New England Journal of Medicine 2013 cited by 1,561

  4. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Hobbs, Arno W. Hoes, Patricia M. Kearney, Juhani Knuuti, Philippe Kolh, T. McDonagh, Bruno Moulin, D Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, P. Vardas, P. Widimsky, Stephan Windecker, Document Reviewers, Christian Funck‐Brentano, D Poldermans, G. Berkenboom, Jacqueline de Graaf, Olivier Descamps, Nina Gotcheva, K. Griffith, Giuseppe Guida, S. Gulec, Y Henkin, Kurt Huber, Y. Antero Kesäniemi, J. Lekakis, Athanasios Manolis, Pedro Marques‐Vidal, L. Masana, John J.V. McMurray, Eugénia Mendes, Zurab Pagava, Terje Pedersen, Eva Prescott, Quitéria Rato, Giuseppe Rosano, Susana Sans, A. Stalenhoef, Lâle Tokgözoğlu, Margus Viigimaa, M. E. Wittekoek, José Luis Zamorano - European Heart Journal 2011 cited by 3,547

  5. Genetics and Outcome of Atypical Hemolytic Uremic Syndrome

    Authors: , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2013 cited by 713

  6. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

    Authors: , , , , , , , , , , , , , , - Kidney International 2012 cited by 567

  7. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arno W. Hoes, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, D. Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Helmut Baumgartner, Christi Deaton, Carlos Aguíar, Nawwar Al‐Attar, Ángeles García, Anna Antoniou, Ioan Mircea Coman, Uri Elkayam, M. A. Gomez-Sanchez, Nina Gotcheva, Denise Hilfiker‐Kleiner, Róbert Gábor Kiss, Anastasia Kitsiou, Karen Konings, Gregory Y.H. Lip, Athanasios Manolis, A. Mebaaza, Iveta Mintāle, Marie-Claude Morice, B. J. M. Mulder, Agnès Pasquet, Susanna Price, S. G. Priori, M. J. Salvador, A. Shotan, Candice Silversides, Sven O. Skouby, J.-I. Stein, P. Tornos, Niels Vejlstrup, Fiona Walker, Carole A. Warnes - European Heart Journal 2011 cited by 1,923

  8. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Hasdai, Arno W. Hoes, Juhani Knuuti, P. Kolh, T. McDonagh, Bruno Moulin, D. Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Adam Torbicki, A. Vahanian, Stephan Windecker, Document Reviewers, Philippe Kolh, Adam Torbicki, Stefan Agewall, Aleš Blinc, M Bulvas, F. Cosentino, T. De Backer, A. Gottsater, Dietrich C. Gulba, Tomasz J. Guzik, B. Jonsson, Gábor Késmárky, Anastasia Kitsiou, W. Kuczmik, Mogens Lytken Larsen, J. Madaric, Jean‐Louis Mas, John J.V. McMurray, A. Micari, M. Mosseri, C. Müller, Ross Naylor, Bo Norrving, Öztekin Oto, Tomasz Pasierski, P.-F. Plouin, F. Ribichini, Jean‐Baptiste Ricco, Luís M. Ruilope, Jean‐Paul Schmid, U. Schwehr, B. G. M. Sol, Muriel Sprynger, Christiane Tiefenbacher, C Tsioufis, H. Van Damme - European Heart Journal 2011 cited by 1,516

  9. Urea levels and cardiovascular disease in patients with chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Liabeuf, Marie Metzger, Élodie Speyer, Thierry Hannedouche, Bruno Moulin, Sébastien Mailliez, Gaëtan Lebrun, Éric Magnant, Gabriel Choukroun, Benjamin Deroure, Adeline Lacraz, G Lambrey, Jean Philippe, Bourdenx, Marie Essig, Thierry Lobbedez, Raymond Azar, Hacène Sekhri, Mustafa Smati, Mohamed Jamali, Alexandre Klein, Michel Delahousse, Christian Combe, Séverine Martin, Isabelle Landru, Éric Thervet, Ziad A. Massy, Philippe Lang, Xavier Belenfant, Pablo Ureña, Carlos Vela, Luc Frimat, Dominique Chauveau, Viktor Panescu, Christian Noël, François Glowacki, Maxime Hoffmann, Maryvonne Hourmant, Dominique Besnier, Angelo Testa, F Kuentz, Philippe Zaoui, Charles Chazot, Laurent Juillard, Stéphane Burtey, Adrien Keller, Nassim Kamar, Denis Fouque, Maurice Laville - Nephrology Dialysis Transplantation 2022 cited by 67

  10. Neutralizing Antibody–Mediated Response and Risk of BK Virus–Associated Nephropathy

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 cited by 110

  11. Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD

    Authors: , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2020 cited by 113

  12. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 cited by 112

  13. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation

    Authors: , , , , , , , , - Journal of Infection 2019 cited by 78

  14. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2020 cited by 76

  15. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Björn Nashan, Przemyslaw Pisarski, Éric Rondeau, Peter Schenker, Claudia Sommerer, Barbara Suwelack, Friedrich Thaiss, Antoine Thierry, Michael S. Wiesener, Oliver Witzke - Kidney International 2019 cited by 101

  16. French recommendations for the management of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luc Mouthon, Collaborators, Marc Bayen, Emmanuel Bergot, S. Berthier, Julia Bosco, Yoram Bouhnik, Benjamin Chaigne, Vincent Cottin, Bruno Crestani, C. Deligny, Vianney Descroix, Dominique Farge, Dominique Godard, B. Granel, Philippe Guilpain, B. Imbert, Alain Le Quellec, Christophe Lega, Catherine Lok, Hélène Maillard, Thierry Martin, G. Pugnet, V. Queyrel, Loïc Raffray, F. Rilliard, Mélanie Romier, Laurence Schuller, Amélie Servettaz - Orphanet Journal of Rare Diseases 2021 cited by 79

  17. Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2011 cited by 131

  18. Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients—Results from a proof-of-concept study

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2020 cited by 54

  19. Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases

    Authors: , , , , , , , , , , - Nephrology Dialysis Transplantation 2022 cited by 37

  20. Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome

    Authors: , , , , , , , , , , , , , , - American Journal of Transplantation 2013 cited by 267

  21. A brief history of vaccines and vaccination

    Authors: , , - Revue Scientifique et Technique de l OIE 2007 cited by 205

  22. Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney Transplantation

    Authors: , , , , , , , , - American Journal of Transplantation 2013 cited by 166

  23. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 162

  24. Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2016 cited by 107